These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 240130)

  • 21. Binding of physostigmine to rat and human plasma and crystalline serum albumins.
    Unni LK; Somani SM
    Life Sci; 1985 Apr; 36(14):1389-96. PubMed ID: 3982219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds.
    Wang C; Williams NS
    J Pharm Biomed Anal; 2013 Mar; 75():112-7. PubMed ID: 23312388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of albumin conformation on binding of phenylbutazone and oxyphenbutazone to human serum albumin.
    Abd Elbary A; Vallner JJ; Whitworth CW
    J Pharm Sci; 1982 Feb; 71(2):241-4. PubMed ID: 7062254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The binding of thiopental to human serum albumin at variable pH and temperature.
    Christensen JH; Andreasen F; Jensen EB
    Acta Pharmacol Toxicol (Copenh); 1983 May; 52(5):364-70. PubMed ID: 6880772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of binding of [3H]-methionine-enkephalin, [3H]-naltrexone and [3H]-dihydromorphine in the mouse vas deferens and the myenteric plexus and brain of the ginea pig.
    Leslie FM; Kosterlitz HW
    Eur J Pharmacol; 1979 Jul; 56(4):379-83. PubMed ID: 477732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of [3H]phenycyclidine to rat and human blood constituents.
    Martin BR; Reynolds ML; Harris LS; Toro-Goyco E
    Biochem Pharmacol; 1984 Feb; 33(3):429-34. PubMed ID: 6704162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphine in children with cancer: impact of age, chemotherapy and other factors on protein binding.
    Mashayekhi SO; Hain RD; Buss DC; Routledge PA
    J Pain Palliat Care Pharmacother; 2007; 21(4):5-12. PubMed ID: 18032310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melphalan concentration dependent plasma protein binding in healthy humans and rats.
    Greig NH; Sweeney DJ; Rapoport SI
    Eur J Clin Pharmacol; 1987; 32(2):179-85. PubMed ID: 3582482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3H-Leu5-enkephalin specific binding to synaptic membrane-comparison with 3H-dihydromorphine and 3H-naloxone.
    Law PY; Loh HH
    Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):409-34. PubMed ID: 705021
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of the gut in the metabolism of strong analgesics.
    Rance MJ; Shillingford JS
    Biochem Pharmacol; 1976 Mar; 25(6):735-41. PubMed ID: 1275955
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of the affinity ligands 14-beta-chloroacetylnaltrexone and 14-beta-bromoacetamidomorphine on [3H]-dihydromorphine binding sites in rat brain.
    Reichman M; Dirksen R; Abood LG; Gala D
    Biochem Pharmacol; 1986 Nov; 35(22):3995-8. PubMed ID: 3022745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding characteristics of mu and kappa agonists in rat brain subcellular fractions.
    Monferini E; Adler MW; Simon EJ
    Life Sci; 1982 Sep 20-27; 31(12-13):1295-8. PubMed ID: 6128655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of fluvastatin to blood cells and plasma proteins.
    Tse FL; Nickerson DF; Yardley WS
    J Pharm Sci; 1993 Sep; 82(9):942-7. PubMed ID: 8229693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The opiate receptor binding interactions of 3H-methionine enkephalin, an opioid peptide.
    Simantov R; Childers SR; Snyder SH
    Eur J Pharmacol; 1978 Feb; 47(3):319-31. PubMed ID: 204498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uric acid. Characterization of its interaction with human serum albumin.
    Campion DS; Bluestone R; Klinenberg JR
    J Clin Invest; 1973 Sep; 52(9):2383-7. PubMed ID: 4727466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of ionic strength on the binding of sodium aurothiosulphate to human serum albumin.
    Pedersen SM
    Biochem Pharmacol; 1985 Dec; 34(24):4319-23. PubMed ID: 3935116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ionic strength and pH on the binding of medium-chain fatty acids to human serum albumin.
    Pedersen AO; Mensberg KL; Kragh-Hansen U
    Eur J Biochem; 1995 Oct; 233(2):395-405. PubMed ID: 7588780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid.
    Barré J; Chamouard JM; Houin G; Tillement JP
    Clin Chem; 1985 Jan; 31(1):60-4. PubMed ID: 3917383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein binding of enprofylline.
    Tegnér K; Borgå O; Svensson I
    Eur J Clin Pharmacol; 1983; 25(5):703-8. PubMed ID: 6420163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characterization of propofol binding to plasma proteins and possible interactions].
    Garrido MJ; Jiménez RM; Rodríguez-Sasiaín JM; Aguirre C; Aguilera L; Calvo R
    Rev Esp Anestesiol Reanim; 1994; 41(6):308-12. PubMed ID: 7838996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.